Morphologic and biochemical hallmarks of apoptosis

Cardiovascular Research

Volumn 45, Issue 3, 2000, Pages 528-537

  Saraste, Antti ^a,b   Pulkki, Kari ^b  

^a UNIVERSITY OF TURKU   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Apoptosis; Histo(patho)logy; Mitochondria; Myocytes

Indexed keywords

CASPASE; CYSTEINE PROTEINASE; DNA FRAGMENT;

APOPTOSIS; CELL DEATH; ELECTROPHORESIS; ENZYME ACTIVATION; ENZYME RELEASE; HEART MUSCLE CELL; HISTOPATHOLOGY; HUMAN; MITOCHONDRION; MOLECULAR BIOLOGY; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

ANIMALS; APOPTOSIS; BIOLOGICAL MARKERS; CASPASES; CELL SIZE; DNA FRAGMENTATION; ENZYME ACTIVATION; HUMANS; IN SITU NICK-END LABELING; MYOCARDIAL ISCHEMIA; MYOCARDIUM; NECROSIS; TAQ POLYMERASE;

EID: 0033957359     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(99)00384-3     Document Type: Review

References (106)

1. Kerr J.F.R., Wyllie A.H., Currie A.R. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer. 26:1972;239-257.
2. Wyllie A.H. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature. 284:1980;555-556.
3. Lazebnik Y.A., Cole S., Cooke C.A., Nelson W.G., Earnshaw W.C. Nuclear events of apoptosis in vitro in cell-free mitotic extracts: a model system for analysis of the active phase of apoptosis. J. Cell Biol. 123:1993;7-22.
4. Solary E., Bertrand R., Kohn K.W., Pommier Y. Differential induction of apoptosis in undifferentiated and differentiated HL-60 cells by DNA topoisomerase I and II inhibitors. Blood. 81:1993;1359-1368.
5. McCarthy N.J., Whyte M.K.B., Gilbert C.S., Evan G.I. Inhibition of Ced-3/ICE-related proteases does not prevent cell death induced by oncogenes, DNA damage, or the Bcl-2 homologue Bak. J. Cell Biol. 136:1997;215-227.
6. Messam C.A., Pittman R.N. Asynchrony and commitment to die during apoptosis. Exp. Cell Res. 238:1998;389-398.
7. Brunet C.L., Gunby R.H., Benson R.S., Hickman J.A., Watson A.J., Brady G. Commitment to cell death measured by loss of clonogenicity is separable from the appearance of apoptotic markers. Cell Death Different. 5:1998;107-115.
8. Gavrieli Y., Sherman Y., Ben-Sasson S.A. Identification of programmed cell death in situ via specific labelling of nuclear DNA fragmentation. J. Cell. Biol. 119:1992;493-501.
9. Kerr J.F.R., Winterford C.M., Harmon B.V. Apoptosis: its significance in cancer and cancer therapy. Cancer. 73:1994;2013-2026.
10. Martin S.J., Green D.R. Protease activation during apoptosis: Death by a thousand cuts? Cell. 82:1995;349-352.
11. Brown S.B., Bailey K., Savill J. Actin is cleaved during constitutive apoptosis. Biochem. J. 323:1997;233-237.
12. Kayalar C., Ord T., Testa M.P., Zhong L.T., Bredesen D.E. Cleavage of actin by interleukin 1 beta-converting enzyme to reverse DNase I inhibition. Proc. Natl. Acad. Sci. 93:1996;2234-2238.
13. Mashima T., Naito M., Noguchi K., Miller D.K., Nicholson D.W., Tsuruo T. Actin cleavage by CPP-32/apopain during the development of apoptosis. Oncogene. 14:1997;1007-1012.
14. Wang K.K.W., Posmantur R., Nath R., et al. Simultaneous degradation of αII- and βII-spectrin by caspase 3 (CPP32) in apoptotic cells. J. Biol. Chem. 273:1998;22490-22497.
15. Vanags D.M., Porn-Ares M.I., Coppola S., Burgess D.H., Orrenius S. Protease involvement in fodrin cleavage and phosphatidylserine exposure in apoptosis. J. Biol. Chem. 271:1996;31075-31085.
16. Martin S.J., O'Brien G.A., Nishioka W.K., McGahon A.J., Saido T.C., Green D.R. Proteolysis of fodrin (non-erythroid spectrin) during apoptosis. J Biol Chem. 270:1995;6425-6428.
17. Brancolini C., Lazarevic D., Rodriquez J., Schneider C. Dismantling cell-cell contacts during apoptosis is coupled to caspase-dependent proteolytic cleavage of beta-catenin. J. Cell Biol. 139:1997;759-771.
18. Kothakota S., Azuma T., Reinhard C., et al. Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis. Science. 278:1997;294-298.
19. Brancolini C., Benedetti M., Schneider C. Microfilament reorganization during apoptosis: the role of Gas2, a possible substrate for ICE-like proteases. EMBO J. 14:1995;5179-5190.
20. Rudel T., Bokoch G.M. Membrane and morphological changes in apoptotic cells regulated by caspase-mediated activation of PAK2. Science. 276:1997;1571-1574.
21. Cardone M.H., Salvesen G.S., Widmann C., Johnson G., Frisch S.M. The regulation of anoikis: MEKK-1 activation requires cleavage by caspases. Cell. 90:1997;315-323.
22. Wen L.P., Fahrni J.A., Troie S., Guan J.L., Orth K., Rosen G.D. Cleavage of focal adhesion kinase by caspases during apoptosis. J. Biol. Chem. 272:1997;26056-26061.
23. Orth K., Chinnayan A.M., Garg M., Froelich C.J., Dixit V.M. The CED-3/ICE-like protease Mch2 is activated during apoptosis and cleaves the death substrate lamin A. J. Biol. Chem. 271:1996;16443-16446.
24. Takashi A., Alnemri E.S., Lazebnik Y.A., et al. Cleavage of lamin A by Mch2 alpha but not CPP32: multiple interleukin-1 beta-converting enzyme-related proteases with distinct substrate recognition properties are active in apoptosis. Proc. Natl. Acad. Sci. 93:1996;8395-8400.
25. Nicholson D.W., Thornberry N.A. Caspases: killer proteases. Trends Biochem. Sci. 22:1997;299-306.
26. Casiano C.A., Martin S.J., Green D.R., Tan E.M. Selective cleavage of nuclear autoantigens during CD95 (Fas/APO-1) -mediated T cell apoptosis. J. Exp. Med. 184:1996;765-770.
27. Fadok V.A., Voelker D.R., Priscilla A.C., Cohen J.J., Bratton D.L., Henson P.M. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 148:1992;2209-2216.
28. Martin S.J., Finucane D.M., Amarante-Mendes G.P., O'Brien G.A., Green D.R. Phosphatidylserine externalisation during CD95-induced apoptosis of cells and cytoplasts requires ICE/CED-3 protease activity. J. Biol. Chem. 271:1996;28753-28756.
29. Saraste A. Morphologic criteria and detection of apoptosis. Herz. 24:1999;189-195.
30. James T.N., Terasaki F., Pavlovich E.R., Vikhert A.M. Apoptosis and pleomorphic micromitochondriosis in the sinus nodes surgically excised from five patients with the long QT syndrome. J. Lab Clin. Med. 122:1993;309-323.
31. Sharov V.G., Sabbah H.N., Shimoyama H., Goussev A.V., Lesch M., Goldstein S. Evidence of cardiocyte apoptosis in myocardium of dogs with chronic heart failure. Am. J. Pathol. 148:1996;141-149.
32. Elsässer A., Schlepper M., Klöverkorn W.-P., et al. Hibernating myocardium: An incomplete adaptation to ischemia. Circulation. 96:1997;2920-2931.
33. 2+-requiring mechanism(s). J. Biol. Chem. 265:1990;17323-17333.
34. Didenko V.V., Hornsby P.J. Presence of double-strand breaks with single-base 3′ overhangs in cells undergoing apoptosis but not necrosis. J. Cell Biol. 135:1996;1369-1376.
35. Bortner C.D., Oldenburg N.B.E., Cidlowski J.A. The role of DNA fragmentation in apoptosis. Trends Cell Biol. 5:1995;21-26.
36. Liu X., Li P., Widlak P., Zou H., Luo X., Garrard W.T., Wang X. The 40-kDa subunit of DNA fragmentation factor induce DNA fragmentation and chromatin condensation during apoptosis. Proc. Natl. Acad. Sci. 95:1998;8461-8466.
37. Enari M., Sakahira H., Yokoyama H., Okawa K., Iwamatsu A., Nagata S. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature. 391:1998;43-50.
38. Sakahira H., Enari M., Nagata S. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature. 391:1998;96-99.
39. Urbano A., McCaffrey R., Foss F. Isolation and characterization of NUC70, a cytoplasmic, hematopoietic apoptotic endonuclease. J. Biol. Chem. 273:1998;34820-34927.
40. Liu X., Zou H., Slaughter C., Wang X. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell. 89:1997;175-184.
41. Tang D., Kidd V.J. Cleavage of DFF-45/ICAD by multiple caspases is essential for its function during apoptosis. J. Biol. Chem. 273:1998;28549-28552.
42. Haunstetter A., Izumo S. Apoptosis: Basic mechanisms and implications for cardiovascular disease. Circ. Res. 82:1998;1111-1129.
43. Kanoh M., Takemura G., Misao J., Hayakawa Y., Aoyama T., Nishikagi K., Noda T., Fujiwara T., Fukuda K., Minatogutchi S., Fujiwara H. Significance of myocytes with positive DNA in situ nick end-labeling (TUNEL) in hearts with dilated cardiomyopathy. Not apoptosis but DNA repair. Circulation. 99:1999;2757-2764.
44. Gold R., Schmied M., Giegerich G., Breitschopf H., Hartung H.P., Toyka K.V., Lassmann H. Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. Lab Invest. 71:1994;219-225.
45. Grosse F., Manns A. Terminal deoxyribonucleotidyl transferase (EC 2.7.7.31). Burrel M.M. Methods in molecular biology. vol. 16. Enzymes of molecular biology:1993;95-105 Humana Press, Totowa, N.J.
46. Saraste A., Pulkki K., Kallajoki M., Henriksen K., Parvinen M., Voipio-Pulkki L.-M. Apoptosis in human acute myocardial infarction. Circulation. 95:1997;320-323.
47. Saraste A., Pulkki K., Kallajoki M., et al. Cardiomyocyte apoptosis and progression of heart failure to transplantation. Eur. J. Clin. Invest. 29:1999;380-386.
48. Petito C.K., Roberts B. Effect of postmortem interval on in situ end-labeling of DNA oligonucleosomes. J. Neuropath. Exp. Neur. 54:1995;761-765.
49. Veinot J.P., Gattinger D.A., Fliss H. Early apoptosis in human myocardial infarcts. Human Path. 28:1997;485-492.
50. Yuan J., Shaham S., Ledoux S., Ellis H.M., Horvitz H.R. The C elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme. Cell. 75:1993;641-652.
51. Thornberry N.A., Bull H.G., Calaycay J.R., et al. A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature. 356:1992;768-774.
52. Alnemri E.S., Livingston D.J., Nicholson D.W., et al. Human ICE/CED-3 protease nomenclature. Cell. 87:1996;171.
53. Kumar S., Kinoshita M., Noda M., Copeland N.G., Jenkins N.A. Induction of apoptosis by the mouse Nedd2 gene, which encodes a protein similar to the product of the Caenorhabditis elegans cell death gene ced-3 and the mammalian IL-1 beta-converting enzyme. Genes Dev. 8:1994;1613-1626.
54. Wang L., Miura M., Bergeron L., Zhu H., Yuan J. Ich-1, an ICE/Ced-3-related gene, encodes both positive and negative regulators of programmed cell death. Cell. 78:1994;739-750.
55. Fernandes T.A., Litwack G., Alnemri E.S. CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme. J. Biol. Chem. 9:1994;30761-30764.
56. Nicholson D.W., Ali A., Thornberry N.A., et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature. 376:1995;37-43.
57. Tewari M., Quan L.T., O'Rourke K., et al. Yama/CPP32β, a mammalian homolog of CED-3, is a crmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell. 81:1995;801-809.
58. Kuida K., Zheng T.S., Na S., et al. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Cell. 384:1996;368-372.
59. Hirsch T., Marchetti P., Susin S.A., et al. The apoptosis-necrosis paradox. Apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death. Oncogene. 15:1997;1573-1581.
60. Woo M., Hakem R., Soengas M.S., et al. Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes. Genes Dev. 12:1998;806-819.
61. Jänicke R.U., Sprengart M.L., Wati M.R., Porter A.G. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J. Biol. Chem. 273:1998;9357-9360.
62. Amarente-Mendes G.P., Finucance D.M., Martin S.J., Cotter T.G., Salvesen G.S., Green D.R. Anti-apoptotic oncogenes prevent caspase-dependent and independent commitment for cell death. Cell Death Different. 5:1998;298-306.
63. Thornberry N.A., Lazebnik Y. Caspases: enemies within. Science. 281:1998;1312-1316.
64. Thornberry N.A., Rano T.A., Paterson E.P., et al. A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J. Biol. Chem. 272:1997;17907-17911.
65. Srinivasula S.M., Ahmad M., Fernandes-Alnemri T., Litwack G., Alnemri E.S. Molecular ordering of the Fas-apoptotic pathway: the Fas/APO-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-like cysteine proteases. Proc. Natl. Acad. Sci. 93:1996;14486-14491.
66. Hirata H., Takahashi A., Kobayashi S., et al. Caspases are activated in a branched protease cascade and control distinct downstream processes in Fas-induced apoptosis. J. Exp. Med. 187:1998;587-600.
67. Slee E.A., Harte M.T., Kluck R.M., et al. Ordering the cytochrome C-initiated caspase cascade: hierarchical activation of caspases -2, -3, -6, -7, -8 and -10 in a caspase-9-dependent manner. J. Cell. Biol. 144:1999;281-292.
68. Ashkenazi A., Dixit V.M. Death receptors: signaling and modulation. Science. 281:1998;1305-1308.
69. Green D.R., Reed J.C. Mitochondria and apoptosis. Science. 281:1998;1309-1312.
70. Kroemer G., Zamzani N., Susin S.A. Mitochondrial control of apoptosis. Immunol. Today. 18:1997;44-51.
71. Fearnhead H.O., Rodriguez J., Govek E.E., et al. Oncogene-dependent apoptosis is mediated by caspase-9. Proc. Natl. Acad. Sci. 95:1998;13664-13669.
72. Soengas M.S., Alarcon R.M., Yoshida H., et al. Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition. Science. 284:1999;156-159.
73. Kluck R.M., Bossy-Wetzel E., Green D.R., Newmeyer D.D. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science. 275:1997;1132-1136.
74. Yang J., Liu X., Bhalla K., et al. Prevention of apoptosis by Bcl-2; release of cytochrome C from mitochondria blocked. Science. 275:1997;1129-1132.
75. Li H., Zhu H., Xu C.J., Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell. 94:1998;491-501.
76. Liu X., Kim C.N., Jemmerson R., Wang X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome C. Cell. 86:1996;147-157.
77. Kluck R.M., Martin S.J., Hoffman B.M., Zhou J.S., Green D.R., Newmeyer D.D. Cytochrome C activation of CPP32-like proteolysis plays a critical role in a xenopus cell-free apoptosis system. EMBO J. 16:1997;4639-4649.
78. Li P., Nijhawan D., Budihardjo I., et al. Cytochrome C and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell. 91:1997;479-489.
79. Srinivasula S.M., Ahmad M., Fernandes-Alnemri T., Alnemri E.S. Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization. Mol. Cell. 1:1998;949-957.
80. Dinsdale D., Zhuang J., Cohen G.M. Redistribution of cytochrome c precedes the caspase-dependent formation of ultracondensed mitochondria, with a reduced inner membrane potential, in apoptotic monocytes. Am. J. Pathol. 155:1999;607-618.
81. Caulin C., Salvesen G.S., Oshima R.G. Caspase cleavage of keratin 18 and reorganisation of intermediate filaments during epithelial cell apoptosis. J. Cell. Biol. 138:1997;1379-1394.
82. Yang F., Sun X., Beech W., et al. Antibody to caspase-cleaved actin detects apoptosis in differentiated neuroblastoma and plaque-associated neurons and microglia in Alzheimer's disease. Am. J. Pathol. 152:1998;379-389.
83. Suurmeijer A.J.H., Wijk J., Veldhuisen D.J., Yang F., Cole G.M. Fractin immunostaining for the detection of apoptotic cells and apoptotic bodies in formalin-fixed and paraffin-embedded tissue. Lab. Invest. 79:1999;619-620.
84. Black S.C., Huang J.Q., Rezaiefar P., et al. Co-localization of the cysteine protease caspase-3 with apoptotic myocytes after in vivo myocardial ischemia and reperfusion in the rat. J. Mol. Cell Cardiol. 30:1998;733-742.
85. Kouroku Y., Urase K., Fujita E., et al. Detection of activated caspase-3 by a cleavage site-directed antiserum during naturally occurring DRG neuron apoptosis. Biochem Biophys Res Commun. 29:1998;780-784.
86. Srinivasan A., Roth K.A., Sayers R.O., et al. In situ detection of activated caspase-3 in apoptotic neurons in the developing nervous system. Cell Death Different. 5:1998;1004-1016.
87. Holly T.A., Drincic A., Byun Y., et al. Caspase inhibition reduces myocyte cell death induced by myocardial ischemia and reperfusion in vivo. J. Mol. Cell Cardiol. 31:1999;1709-1715.
88. Harsdorf R., Li P-F., Dietz R. Signaling pathways in reactive oxygen species-induced cardiomyocyte apoptosis. Circulation. 99:1999;2934-2941.
89. Koglin J., Granville D.J., Glysing-Jensen T., et al. Attenuated acute cardiac rejection in NOS2 -/- recipients correlates with reduced apoptosis. Circulation. 99:1999;836-842.
90. Narula J., Pandey P., Abrustini E., et al. Apoptosis in heart failure: release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy. Proc. Natl. Acad. Sci. 96:1999;8144-8149.
91. Gottlieb R.A., Gruol D.L., Zhu J.Y., Engler R.L. Preconditioning in rabbit cardiomyocytes. Role of pH, vacuolar proton ATPase, and apoptosis. J. Clin. Invest. 97:1996;2391-2398.
92. Yaoita H., Oqawa K., Maehara K., Maruyama Y. Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor. Circulation. 97:1998;276-281.
93. Majno G., Joris I. Apoptosis, oncosis and necrosis. An overview of cell death. Am. J. Pathol. 146:1995;3-15.
94. Xiang J., Chao D.T., Korsmeyer S.J. BAX-induced cell death may not require interleukin 1 beta-converting enzyme-like proteases. Proc. Natl. Acad. Sci. 93:1996;14559-14563.
95. Leist M., Single B., Castoldi A.F., Kühnle S., Nicotera P. Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J. Exp. Med. 185:1997;1481-1486.
96. Leist M., Nicotera P. The shape of cell death. Biochem. Biophys. Res. Comm. 236:1997;1-9.
97. Buja L.M. Modulation of myocardial response to ischemia. Lab Invest. 78:1998;1345-1373.
98. Kajstura J., Cheng W., Reiss K., et al. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest. 74:1996;86-107.
99. Gottlieb R.A., Burleson K.A., Kloner R.A., Babior B.M., Engler R.L. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J. Clin. Invest. 94:1994;1621-1628.
100. Ohno M., Takemura G., Ohno A., et al. Apoptotic myocytes in infarct area in rabbit hearts may be oncotic myocytes with DNA fragmentation: Analysis by immunogold electron microscopy combined with in situ nick end-labeling. Circulation. 98:1998;1422-1430.
101. Webster K.A., Discher D.J., Kaiser S., Hernandez O., Sato B., Bishopric N.H. Hypoxia-activated apoptosis of cardiac myocytes requires reoxygenation or a pH shift and is independent of p53. J. Clin. Invest. 104:1999;239-252.
102. Leri A., Claludio P.P., Li Q., et al. Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl-2 to Bax protein ratio in the cell. J. Clin. Invest. 101:1998;1326-1342.
103. Shizukuda Y., Buttrick P.M., Geenen D.L., Borczuk A.C., Kitsis R.N. Sonnenblick E.H., β-adrenergic stimulation causes cardiocyte apoptosis: influence of tachycardia and hypertrophy. Am J Physiol. 275:1998;H961-H968.
104. Cosulich S.C., Horiuchi H., Zerial M., Clarke P.R., Woodman P.G. Cleavage of rabaptin-5 blocks endosome fusion during apoptosis. EMBO J. 16:1997;6182-6192.
105. Koseki T., Inohara N., Chen S., Núñez G. ARC, an inhibitor of apoptosis expressed in skeletal muscle and heart interacts selectively with caspases. Proc. Natl. Acad. Sci. 95:1998;5156-5160.
106. Cheng W., Li B., Kajstura J., et al. Stretch-induced programmed myocyte cell death. J. Clin. Invest. 96:1995;2247-2259.